Urte Gayko - Net Worth and Insider Trading
Urte Gayko Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Urte Gayko owns 1 companies in total, including Summit Therapeutics Inc (SMMT) .
Click here to see the complete history of Urte Gayko’s form 4 insider trades.
Insider Ownership Summary of Urte Gayko
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SMMT | Summit Therapeutics Inc | 2021-11-03 | director |
Urte Gayko Trading Performance
Urte Gayko Ownership Network
Ownership Network List of Urte Gayko
Ownership Network Relation of Urte Gayko
Urte Gayko Owned Company Details
What does Summit Therapeutics Inc do?
Who are the key executives at Summit Therapeutics Inc?
Urte Gayko is the director of Summit Therapeutics Inc. Other key executives at Summit Therapeutics Inc include Chief Financial Officer Ankur Dhingra , director & 10 percent owner & See Remarks Robert W Duggan , and VP & Corporate Controller Jeffrey R Maranian .
Summit Therapeutics Inc (SMMT) Insider Trades Summary
Over the past 18 months, Urte Gayko made no insider transaction in Summit Therapeutics Inc (SMMT). Other recent insider transactions involving Summit Therapeutics Inc (SMMT) include a net purchase of 120,400 shares made by Ankur Dhingra , a net purchase of 115,321 shares made by Maky Zanganeh , and a net purchase of 2,976,190 shares made by Manmeet Singh Soni .
In summary, during the past 3 months, insiders sold 0 shares of Summit Therapeutics Inc (SMMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Summit Therapeutics Inc (SMMT) were sold and 3,211,911 shares were bought by its insiders, resulting in a net purchase of 3,211,911 shares.
Summit Therapeutics Inc (SMMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Summit Therapeutics Inc Insider Transactions
Urte Gayko Mailing Address
Above is the net worth, insider trading, and ownership report for Urte Gayko. You might contact Urte Gayko via mailing address: C/o Parmacyclics, Inc., 995 East Arques Avenue, Sunnyvale Ca 94085.